ROBERT S. ETTINGER, MD

Plain English
This study examined blood samples from 87 patients with systemic lupus erythematosus (SLE), a disease that affects multiple organs and is difficult to manage. Researchers found three distinct protein patterns in the blood that are linked to specific organ issues and immune responses in SLE patients; notably, one new pattern was associated with kidney problems and a higher risk of long-term organ damage. These findings are important because they offer better ways to understand and potentially treat SLE by targeting these specific immune mechanisms. Who this helps: Patients with systemic lupus erythematosus, particularly those experiencing kidney issues.

Plain English
This study looked at how residency program directors in four medical specialties feel about trainee doctors refusing to provide gender-affirming care based on personal beliefs. Out of 257 program directors surveyed, about 24% shared their thoughts on this issue, highlighting that attitudes toward such refusals vary by medical specialty, location, and existing regulations. The findings highlight a significant challenge in creating consistent policies that respect both personal beliefs and the need for gender-affirming care in healthcare. Who this helps: This helps patients seeking gender-affirming care, as well as program directors and medical institutions.

Plain English
This study looked at how dentists plan treatments for older adults, especially those who are frail or have difficulty with daily activities. The researchers found that many treatment strategies aren't based on solid evidence, and successful dental care needs to consider each patient's overall health and personal situation. Understanding these factors can lead to better oral health outcomes for older patients. Who this helps: This benefits older adults who need dental care and their health care providers.

Plain English
This paper examines how to treat burns and other thermal injuries to the penis and scrotum, areas that are less commonly studied compared to other types of burns. The review pulls together existing knowledge, highlighting treatment options like skin grafts and surgical techniques, which can significantly affect recovery and long-term outcomes. Proper management of these injuries is crucial because they can lead to serious issues for patients, including permanent damage and psychological impacts. Who this helps: This information benefits patients who suffer genital thermal injuries and the doctors treating them.

Plain English
This study looked at how COVID-19 affected the dental health of people with special needs. Researchers found that these individuals faced greater risks due to limited access to dental care, relying mostly on emergency services instead of regular check-ups and treatments. The introduction of telehealth helped provide some support and access to care during this time, which is important for maintaining their oral health and overall well-being. Who this helps: This benefits patients with special needs and their caregivers.

Plain English
This study looked at the dental treatment needs of vulnerable adults who received care under general anesthesia (GA) between 2007 and 2017. Out of 414 patients, 247 were treated under GA, with most of them having disabilities. The main reason for needing GA was pain, and after treatment, the failure rate of teeth was low at 4%, suggesting that the care provided was mostly effective. Regular check-ups could help prevent future dental emergencies. Who this helps: This benefits vulnerable patients who need dental care and the healthcare providers working with them.

Plain English
This study looked at how to effectively plan dental care for older adults, particularly those who are frail or have difficulty caring for themselves. The researchers found that many treatment options available may not be based on solid evidence, highlighting the need for dentists to consider the patients' overall health and daily lives when creating dental treatment plans. This matters because personalized dental care can significantly improve the quality of life for older adults, ensuring their oral health aligns with their specific needs. Who this helps: This helps older adults and their caregivers.

Plain English
This study focused on a specific type of B cell that shows increased levels of a marker called CD11c in patients with systemic lupus erythematosus (SLE), a type of autoimmune disease. Researchers found that these CD11c B cells are similar to those involved in chronic infections and have distinct properties that set them apart from other B cell types. They observed that these cells may be linked to the development of autoimmunity due to issues in how B cells are normally regulated. Who this helps: This research benefits patients with autoimmune diseases like lupus by providing insights into the mechanisms behind their condition.

Plain English
This study looked at patients who underwent a specific jaw surgery called the Le Fort I osteotomy, focusing on how well the jaw stayed in place one year after the procedure. Researchers found that there were no major issues like incorrect jaw alignment or the need for additional surgeries in the 58 patients monitored, and the changes in jaw position averaged less than 1 mm, indicating strong stability. This is important because it shows that the method used for securing the jaw can effectively maintain its new position over time. Who this helps: This helps patients undergoing jaw surgery, particularly those with conditions like cleft lip and palate.

Plain English
This study looked at a surgery called the cleft Le Fort I osteotomy, which is used to help patients with cleft palates by adjusting the position of the upper jaw. Researchers modified the surgical technique to release scar tissue and improve stability after surgery, finding that patients can have an average jaw advancement of 6.1 mm without significant movement backward, with less than 1 mm of relapse after one year. This matters because it shows that the modified approach allows for effective jaw correction while maintaining stability over time. Who this helps: This helps patients with cleft palates and their doctors.

Plain English
This study looked at how immune cells in a special mouse model (NOD-mice) not only attack pancreatic tissue, leading to type 1 diabetes (T1D), but also cause damage to nerve tissue. Researchers found that when T cells from these mice were transferred to other mice, they induced T1D and also caused nerve inflammation (neuritis), primarily involving T cells. Specifically, 70% of the nerve-infiltrating CD4 T cells showed different characteristics compared to those in the pancreas and spleen, indicating unique immune responses in different tissues. Who this helps: This research helps patients with type 1 diabetes, particularly those experiencing nerve-related complications.

Plain English
This study looked at how the CD40-CD40L pathway affects the immune system and its role in autoimmune diseases. It found that the interaction between CD40 on B cells and CD40L on T cells is crucial for creating antibodies and a strong immune response. Understanding this pathway can help develop new treatments that are currently being tested in clinical trials, which could improve outcomes for patients with autoimmune disorders. Who this helps: This helps patients with autoimmune diseases.

Plain English
This research studied a new method to create powerful antibodies that block interleukin-21 (IL-21), a protein linked to autoimmune diseases. The scientists found that their new approach, which involved alternating immunizations with IL-21 from both humans and monkeys, produced stronger antibodies than using just human IL-21. One of the resulting antibodies, called MEDI7169, has a strong ability to inhibit IL-21 activity and is being developed as a treatment for autoimmune conditions. Who this helps: This benefits patients with autoimmune diseases.

Plain English
This study looked at natural killer (NK) cells in patients with systemic lupus erythematosus (SLE), an autoimmune disorder. Researchers found that a specific marker called Ki67 was present on NK cells in higher amounts in SLE patients compared to healthy individuals, and this was associated with more severe disease and kidney inflammation. This means that NK cells play a significant role in the disease and may be a target for new treatments. Who this helps: This helps patients with systemic lupus erythematosus by identifying potential new treatment options.

Plain English
This paper focuses on how people with Alzheimer's disease commonly experience poor oral health due to cognitive decline. The authors found that integrating oral care into the overall health routine for these patients as early as possible can prevent quick deteriorations in oral health. This matters because good oral health is vital for avoiding complications like pain and severe infections, which can greatly affect the life quality of patients. Who this helps: This helps patients with Alzheimer's and their caregivers by highlighting the importance of oral health in overall care.

Plain English
Researchers studied a new treatment called VIB4920, which targets a specific protein (CD40L) involved in autoimmune diseases. In a trial with rheumatoid arthritis patients, over 50% of those receiving higher doses experienced less disease activity or went into remission, and the treatment also lowered levels of harmful autoantibodies. This is important because it shows that VIB4920 could effectively reduce symptoms of autoimmune diseases while being safer than earlier treatments. Who this helps: This benefits patients with autoimmune diseases, particularly rheumatoid arthritis.

Plain English
This study focused on improving the healing of bone fractures, specifically addressing the problem of nonunions, which occur in 5-10% of the 6.3 million fractures in the U.S. each year. Researchers created an implant that combines the drug deferoxamine (DFO) with hyaluronic acid, allowing it to stay at the fracture site longer and significantly enhance blood vessel formation. The results showed that this treatment led to a 91% success rate in bone healing, compared to only 20% in untreated cases, indicating a 3.5 times better outcome. Who this helps: This helps patients experiencing fractures, particularly those at risk of nonunion.

Plain English
This study looked at a newborn with a large spinal defect (myelomeningocele) complicated by severe spinal curvature (kyphosis). Instead of surgery to correct the curvature, which posed too many risks, doctors used a special material called acellular dermal matrix to cover the defect. After 8 weeks, the area healed completely, showing that this material can effectively serve as an alternative solution when there's not enough local tissue for repair. Who this helps: This benefits newborn patients with complex spinal defects and their families by providing safer treatment options.

Plain English
This study focused on how to better manage dental health for frail older adults and people with special needs, who are more prone to cavities. Researchers found that assessing each person's specific risk can help tailor treatment plans, ensuring they receive the care suited to their unique situation. By using this personalized approach, patients can potentially avoid serious dental issues. Who this helps: This helps patients with special needs and frail older adults.

Plain English
This study looked at how specific proteins in the blood relate to different forms of systemic lupus erythematosus (SLE), particularly lupus nephritis (kidney involvement) and discoid lupus (skin involvement). Researchers found that two groups of proteins in patients with lupus nephritis were linked to inflammation and tissue changes, while patients with discoid lupus showed higher levels of certain antibodies and interleukin-23. This research is important because it suggests that measuring these proteins can help monitor different aspects of SLE more effectively than existing methods. Who this helps: This helps patients with lupus and their doctors by providing better tools for monitoring the disease.

Plain English
This study looked at two families with men who have specific dental issues: taurodontism (larger pulp cavities in teeth), microdontia (smaller-than-normal teeth), and dens invaginatus (teeth with unusual grooves). Researchers found two genetic changes (missense variants) linked to these conditions in the affected men from both families, showing how these changes affect tooth development and cell movement. Understanding these genetic causes is important because it can help doctors diagnose and manage these dental issues more effectively. Who this helps: This helps patients with dental anomalies and their families.

Plain English
This study looked at how dental schools around the world are teaching about dental care for older adults. Researchers found that most countries do not offer a separate course on geriatric dentistry, with Japan being an exception, and there are not enough trained dentists in this field. Despite an increase in research on the topic, much of it is not published in English, which limits its reach. Who this helps: This helps older patients who need better dental care and the dentists who treat them.

Plain English
This study looked at how a protein called galectin-9 (Gal-9) affects autoimmune responses in mice with lupus. Researchers found that when they gave Gal-9 to these mice, it reduced harmful immune reactions tied to a signaling pathway that involves a receptor called TLR7. Specifically, there was a notable decrease in autoimmune activity, showing that Gal-9 can help control the immune system's overreaction in lupus. Who this helps: This research benefits patients with lupus by highlighting a potential new way to manage their symptoms.

Plain English
This study looked at a specific type of immune cell called CD11cT-betB cells in patients with systemic lupus erythematosus (SLE), a condition where the immune system attacks the body. Researchers found that these cells are more common in SLE patients, especially in kidney damage, and they can turn into cells that produce harmful antibodies. The study highlights the role of these cells in SLE and how they might contribute to the disease. Who this helps: This helps patients with systemic lupus erythematosus and their doctors.

Plain English
This study looked at how certain immune system receptors, TLR7 and TLR9, relate to cutaneous lupus, a skin condition similar to a more severe autoimmune disease called systemic lupus erythematosus (SLE). Researchers found that mice lacking TLR9 developed severe skin lesions resembling those in people with cutaneous lupus, showing specific immune cells were involved. This is important because it highlights the role of TLR9 in regulating immune response and provides a new way to study skin lupus diseases. Who this helps: This helps patients with cutaneous lupus and researchers studying autoimmune diseases.

Plain English
This study examined how CD40/CD40L interactions are important for developing autoimmune diseases, specifically looking at how they work with immune checkpoints and co-stimulatory pathways. Researchers found that for certain autoimmune diseases like primary Sjögren's syndrome and thyroid disease in specific mouse models, blocking the CD40 signaling reduced inflammation and autoantibody production. However, in other models lacking PD-1, blocking CD40 did not help and sometimes even worsened the diseases, indicating that different mechanisms are at play depending on which immune receptors are involved. Who this helps: This research helps doctors understand better how to treat certain autoimmune diseases effectively.

Plain English
This study looked at how certain antibodies called IgE are involved in autoimmune diseases, where the body mistakenly attacks itself. Researchers found that IgE autoantibodies can activate immune cells in a way that contributes to these diseases, enhancing immune responses and affecting B and T cells. This is important because it helps us understand how these antibodies might worsen autoimmune disorders, which could lead to better treatments for patients. Who this helps: This helps patients with autoimmune diseases.

Plain English
This study looked at how and why some food allergies, like those to peanuts, last a lifetime. Researchers discovered that rather than being sustained by long-lasting cells that produce IgE antibodies, persistent allergic reactions are driven by special memory cells that reactivate whenever the person is exposed to the allergen again. They identified that these memory cells can keep producing IgE in response to allergens for many years. Who this helps: This helps patients with lifelong food allergies by providing insights for new therapies.

Plain English
This study focused on a specific type of immune cell called B cells, particularly a group known as CD11cT-betB cells. Researchers found that these cells can expand in numbers when the immune system is continuously activated, and they may have the ability to recognize and respond to the antigens that initially triggered their growth. Understanding these B cells is crucial as they might play a significant role in various health conditions and diseases, including how the body responds to infections or manages certain diseases. Who this helps: This helps patients with immune-related diseases and the doctors treating them.

Plain English
This study looked at how blocking a protein called BAFF affects the development of type 1 diabetes (T1D) in mice. Researchers found that temporarily stopping BAFF allowed mice to develop protective immune cells that help prevent T1D. Specifically, this treatment made the mice resistant to T1D and increased certain beneficial B lymphocytes, while a combination treatment with another drug, anti-CD20, counteracted the positive effects of BAFF suppression. Who this helps: This research benefits patients at high risk for type 1 diabetes by exploring new treatment strategies.

Plain English
This research focused on developing a new antibody called MEDI4212 that both neutralizes a type of antibody linked to allergies (IgE) and targets the cells that produce it. The scientists created different versions of MEDI4212 that successfully blocked IgE's effects and improved their ability to destroy IgE-producing cells. The study found that these enhanced versions could significantly reduce IgE levels and potentially offer lasting relief from allergies. Who this helps: This benefits patients with allergic asthma.

Plain English
This study looked at how a type of antibody called IgE impacts immune responses in patients with systemic lupus erythematosus (SLE), an autoimmune disease. Researchers found that specific IgE antibodies could significantly boost the activity of certain immune cells, leading to increased production of interferon-α, a molecule that can worsen autoimmune reactions. They discovered that the higher the levels of these IgE antibodies in the patients' blood, the more severe their disease tended to be. Who this helps: This helps patients with autoimmune diseases like lupus by providing insight into new treatment possibilities.

Plain English
This study looked at how immune system problems early in life can lead to autoimmune diseases, like Sjögren's syndrome, later on. Researchers found that by blocking a specific protein called CD40L in young mice, they could prevent the development of autoimmune signs and symptoms as the mice aged. This indicates that treating immune issues early can effectively stop or lessen autoimmune diseases that are linked to certain antibodies, potentially impacting multiple conditions like thyroiditis and diabetes. Who this helps: This benefits patients at risk of autoimmune diseases and their doctors by highlighting the importance of early intervention.

Plain English
In this study, researchers looked at a protein called BAFF and its role in how cigarette smoke affects the lungs, particularly in causing specific antibodies and inflammatory tissue changes in mice. They found that BAFF levels increased significantly in both smokers and mice exposed to cigarette smoke, which persisted over time; blocking BAFF reduced harmful antibody levels and inflammation after quitting smoking. This research highlights the potential of targeting BAFF as a treatment to reduce lung damage and autoimmune issues in smokers. Who this helps: Patients with chronic obstructive pulmonary disease (COPD) or those recovering from smoking.

Plain English
This study looked at how two proteins on B cells, CD19 and CD32b, influence how these immune cells respond to signals. Researchers found that when both proteins were targeted together, they significantly reduced B cell activity: using a combined approach, they observed a strong inhibition of B cell growth and antibody production. This finding is important because it suggests that treating certain conditions may require strategies that consider multiple signals affecting B cells, which could lead to better therapies. Who this helps: This helps patients with autoimmune diseases or cancers where B cells are involved.

Plain English
This study looked at how certain immune cell structures called ectopic follicles develop in a mouse model of Sjögren's syndrome, which is an autoimmune disease that affects glands like the salivary glands. Researchers found that these mouse subjects started showing signs of autoimmune responses, including specific autoantibodies, at 8 weeks of age, with ectopic follicles appearing later between 12 to 16 weeks. Understanding these processes is important because it could lead to new ways to target harmful immune responses without disrupting the body's overall immune protection. Who this helps: This helps patients with autoimmune conditions, especially Sjögren's syndrome.

Plain English
This study examined the effects of blocking a protein called CXCL13 on the immune system in mice with arthritis. Researchers found that using an antibody to inhibit CXCL13 improved the structure of lymphoid follicles, which are important for immune function, while not changing the overall levels of antibodies produced in response to infections. This matters because managing the immune response in autoimmune diseases could help reduce inflammation and tissue damage. Who this helps: Patients with autoimmune diseases like arthritis.

Plain English
This study looked at new treatments that target B cells, which are vital parts of the immune system but can also lead to diseases like lupus, rheumatoid arthritis, and multiple sclerosis. Researchers found that using drugs like rituximab, which depletes B cells, can significantly benefit patients, indicating that there’s great potential for other therapies currently in development. These advancements are important because understanding how B cells contribute to autoimmune diseases can lead to better treatments tailored for patients. Who this helps: This helps patients with autoimmune diseases and their doctors by offering new treatment options.

Plain English
This study looked at how a specific surgical procedure (posterior-middle vault expansion) affects the forehead shape of young children with a condition called sagittal craniosynostosis, where the skull bones fuse too early. Researchers analyzed 43 patients under 1 year old before and two years after surgery and found that their forehead shape improved significantly; most patients' measurements moved from significantly larger than average to nearly normal. This is important because it shows that this surgery can help correct forehead deformities without needing more complex procedures. Who this helps: This benefits young patients with sagittal craniosynostosis and their families by providing a safer and effective treatment option.

Plain English
This study looked at how two proteins, IL-21 and BAFF, affect the immune system's B cells, which are important for producing antibodies. Researchers found that IL-21 is the most powerful signal for activating B cells, while BAFF helps them survive and grow. Together, they help maintain a strong immune response, with BAFF being able to compensate for some functions of another protein called CD40. However, BAFF cannot prevent B cells from dying when triggered in a certain way by IL-21, but combining IL-21 with CD40 activation can turn that death signal into a signal that promotes antibody-producing cells. Who this helps: This helps patients by improving understanding of B cell behavior, potentially leading to better treatments for autoimmune diseases and vaccine responses.

Plain English
This study looked at specific parts of a protein related to IgE, an antibody involved in allergic reactions, to find ways to treat allergies caused by too many IgE-producing B cells. Researchers found that antibodies targeting the junction of two segments of the protein successfully attached to B cells that produce IgE, leading to a reduction in their activity without affecting other immune cells. This is important because it could lead to a more targeted allergy treatment with fewer side effects. Who this helps: Patients with allergies caused by excess IgE.

Plain English
Researchers studied how a drug called mycophenolic acid (MPA) affects B cells, which are important for producing antibodies and can contribute to autoimmune diseases. They found that MPA significantly reduces the growth and development of these B cells, especially in patients with rheumatoid arthritis, by preventing their activation and stopping them from becoming plasma cells that produce antibodies. However, MPA does not affect the existing plasma cells, which means it can't reduce symptoms caused by antibodies that have already been made. Who this helps: This benefits patients with autoimmune disorders, particularly those who rely on treatments to manage their symptoms.

Plain English
This study looked at how normal and mutated forms of a specific receptor (TNFR1) work together to increase inflammation in patients with TNF receptor 1-associated periodic fever syndrome (TRAPS). The researchers found that in TRAPS patients, the mutated receptor collects inside cells instead of working properly on the surface, causing more inflammation through a specific pathway. They showed that this inflammation is especially strong when both normal and mutant receptors interact, which could help explain why some patients benefit only partially from treatments that block TNF activity. Who this helps: This helps patients with TRAPS and doctors treating them.

Plain English
This study followed an 8-year-old boy with lymphoblastic lymphoma who also had distinctive skin spots. Researchers discovered he had two mutations in the MSH6 gene, which plays a role in repairing DNA errors. This is important because it highlights the risk for childhood cancers in patients with these mutations, the potential for misdiagnosis with other conditions, and the need for careful monitoring and further research on treatment challenges. Who this helps: This helps patients, their families, and doctors by improving understanding of hereditary cancer risks.

Plain English
This study focused on a 3-year-old boy who had a condition causing low platelet counts and severe anemia, along with ear infections. After testing, doctors discovered he had a rare genetic issue called ADAMTS13 deficiency. Instead of giving him regular plasma treatments to prevent problems, they successfully treated him with plasma only when symptoms appeared, suggesting that this reactive approach might be a better option for some patients with this condition. Who this helps: This helps patients with inherited ADAMTS13 deficiency and their doctors.

Plain English
This study looked at how a gene called Dlk1 affects the development and function of B lymphocytes, which are a type of immune cell. Researchers created mice without the Dlk1 gene and found that these mice had more transitional B cells but fewer follicular B cells, along with increased levels of two antibody types (IgG1 and IgG3). This is important because it shows that Dlk1 is crucial for normal B cell development and how the immune system responds to infections. Who this helps: This helps patients by improving our understanding of immune responses, which could lead to better treatments for infections and immune-related diseases.

Plain English
This study looked at a molecule called IL-21, which is important for how immune cells called B cells work. Researchers found that while IL-21 can help activate B cells to produce antibodies for fighting infections and cancer, it can also lead to problems in autoimmune diseases where the body mistakenly attacks itself. Understanding how IL-21 works could help develop new treatments for conditions where the body is making too many harmful antibodies or not enough helpful ones. Who this helps: This research benefits patients with autoimmune diseases and those with infections or cancer.

Plain English
This study focused on a substance called interleukin 21 (IL21), which plays a key role in the immune system and is linked to autoimmune diseases. Researchers found that higher levels of IL21 are often found in people with these diseases and that it helps produce harmful antibodies. This is important because targeting IL21 could lead to new treatments for autoimmune diseases, helping to control autoimmune responses that cause damage to the body. Who this helps: This helps patients with autoimmune diseases.